AllisonLornaAgwuMDScM, FAAP, FIDSA
Pediatric Infectious Disease • Baltimore, MDHIV/AIDS Pediatrics, Pediatric Infections Associated with Transplant/Immunocompromised States, Perinatal Infections
Associate Professor, Pediatric and Adult Infectious Diseases, Johns Hopkins University School of Medicine
Dr. Agwu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 North Wolfe Street
Rubenstein BLDG Lower Level
Baltimore, MD 21287Phone+1 443-997-5437Fax+1 410-955-1491
Education & Training
Johns Hopkins UniversityFellowship, Infectious Disease, 2006 - 2007- Johns Hopkins UniversityFellowship, Pediatric Infectious Diseases, 2003 - 2006
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine/Pediatrics, 1999 - 2003
University of Maryland School of MedicineClass of 1999
Certifications & Licensure
MD State Medical License 2007 - 2026
OH State Medical License 2000 - 2003
American Board of Pediatrics Pediatric Infectious Diseases
Clinical Trials
- Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy Start of enrollment: 2011 Mar 01
- Connect to Protect (C2P): Building a Community-Based Infrastructure for HIV Prevention Start of enrollment: 2011 Nov 01
- PHASES: Provision of HIV Treatment at ATN Sites: An Evaluation for Stakeholders Start of enrollment: 2015 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsPharmacokinetics and Safety of Bictegravir in Pregnant and Postpartum Persons With HIV and Their Infants.Kathleen M Powis, Mauricio Pinilla, Flynn McMorrow, Alice Stek, Kristina M Brooks
Journal of Acquired Immune Deficiency Syndromes. 2025-03-01 - 1 citationsSafety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a ...Carolyn Bolton Moore, Kristin Baltrusaitis, Brookie M Best, John H Moye, Ellen Townley
The Lancet. HIV. 2025-03-01 - Policy Recommendations to Support Equitable Access to Long-Acting Injectables for Human Immunodeficiency Virus Prevention and Treatment: A Policy Paper of the Infectio...Julia L Marcus, Andrea Weddle, Colleen F Kelley, Allison Agwu, Sheila Montalvo
Clinical Infectious Diseases. 2025-01-28
Journal Articles
- HIV Preexposure Prophylaxis Among Adolescents in the USErrol Fields, Allison L Agwu, JAMA Pediatrics
- The Latent HIV Reservoir Resides Primarily in CD32- CD4+ T Cells in Perinatally, HIV-Infected Adolescents with Long-Term Virologic SuppressionAllison Agwu, Deborah Persaud, The Journal of Infectious Diseases
Authored Content
- HIV Preexposure Prophylaxis Among Adolescents in the USMay 2020
Press Mentions
ID Expert Sees ‘A Lot to Lose’ in Legislation Proposing NIAID 3-Way SplitFebruary 28th, 2025
Know Your Respiratory Virus Enemies This Season!January 16th, 2025
Study Finds That Tennessee’s Shift in HIV Prevention Funding Will Lead to Poorer Health Outcomes for Its ResidentsJuly 11th, 2024- Join now to see all
Grant Support
- Strategies to Achieve Viral Suppression for Youth with HIV (The SAVVY Study)JOHNS HOPKINS UNIVERSITY2023–2028
- Haart Initiation In Behaviorally Hiv-Infected YouthNational Institute Of Allergy And Infectious Diseases2010–2011
Professional Memberships
- Fellow
- Fellow
Other Languages
- Spanish
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/allison-agwu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
